NSC117079 NEW
| Price | $787 | $1320 |
| Package | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-10 |
Product Details
| Product Name: NSC117079 | CAS No.: 500363-63-3 |
| Purity: 98.11% | Supply Ability: 10g |
| Release date: 2025/11/10 |
Product Introduction
Bioactivity
| Name | NSC117079 |
| Description | NSC117079 is a novel PHLPP1/2 (Pleckstrin homology domain and leucine rich repeat protein phosphatase) inhibitor that activates neuronal AKT and ameliorates staurosporine-induced cell death in neurons. |
| In vitro | The in vitro activity of NSC117079 was evaluated in primary rat cortical neurons and astrocytes. Neurons were pretreated with NSC117079 (10–100 μM) for 35 minutes after nutrient deprivation, or co-treated with staurosporine (50–200 nM) for 24 hours; astrocytes were treated for 24 hours after seeding. NSC117079 activated AKT signaling and showed protective effects in neurons, but inhibited signaling and reduced viability in astrocytes [1]. |
| In vivo | The in vivo activity of NSC117079 was evaluated in a mouse model of osteoarthritis induced by destabilization of the medial meniscus (DMM). Twelve-week-old male C57BL/6 mice underwent right knee DMM surgery, followed by a single intra-articular injection of NSC117079 (8 mM, 3 μL; estimated intra-articular concentration ~4 mM) at 7 weeks post-surgery. The results showed that NSC117079 significantly reduced mechanical allodynia, preserved normal activity levels, and slowed articular cartilage degradation [2]. |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.22 mM), Sonication is recommended. DMSO : 40 mg/mL (84.48 mM), Sonication is recommended. |
| Keywords | NSC-117079 | NSC117079 |
| Inhibitors Related | Osunprotafib | PTP1B-IN-22 | Disodium monofluorophosphate | β-Glycerophosphate disodium salt pentahydrate | Idoxuridine | Tartaric acid disodium dihydrate | Cyclosporine | Stearic acid | Cis-5-Norbornene-exo-2,3-dicarboxylic Anhydride | CaMKP Inhibitor | L-Ascorbic acid 2-phosphate magnesium | Trimyristin |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1320.00/100mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-05-16 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY